Frusapex Drops

Frusapex Drops are a prescription veterinary medication containing Frusemide (Furosemide), used primarily as a loop diuretic to treat oedema in dogs and cats. The product is a staple in veterinary clinics for managing conditions associated with fluid retention, such as congestive heart failure.

The brand was originally developed by Apex Laboratories, an Australian pharmaceutical company founded in 1962 that specialized in animal health. In recent years, the brand has come under the ownership of Dechra Pharmaceuticals. While Dechra is a global leader in the veterinary market, this specific product continues to be manufactured primarily in Australia to serve the regional veterinary market.

Today, the brand operates as part of Dechra's extensive portfolio of endocrine, specialist, and critical care products for companion animals. Ownership transitioned to EQT (a global investment firm) following a multi-billion dollar acquisition of Dechra, ensuring the brand remains a key player in the international animal health sector moving into the mid-2020s.